FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3034605260> ?p ?o ?g. }

• W3034605260 endingPage "148" @default.
• W3034605260 startingPage "143" @default.
• W3034605260 abstract "The current experiment was performed to investigate the effect of LncRNA NORAD on the sensitivity of miR-410-3p to drug resistance of osteosarcoma cells. The cisplatin-resistant cell line HOS/DDP was induced; si-NC, si-NORAD, miR-NC, miR-410-3p, pcDNA-NC, and pcDNA-NORAD were transfected into HOS/DDP cells, respectively; record as a si-NC group, si-NORAD group, miR-NC group, miR-410-3p group, pcDNA-NC group, pcDNA-NORAD group; si-NORAD was co-transfected into HOS/DDP cells with anti-miR-NC, anti-miR-410-3p, recorded as an anti-miR-NC+si-NORAD group and anti-miR-410-3p+si-NORAD group. Real-time quantitative PCR (RT-qPCR) was used to detect LncRNA NORAD, miR-410-3p and multidrug resistance protein 1 (MRP1) mRNA expression levels; Western blot was used to detect cyclin D1 (CyclinD1), MRP1, phosphorylated (p-p65), phosphorylated IкBα (p-IкBα) protein expression; cell counting kit 8 (CCK-8) was used to detect cell viability; dual luciferase report assay to detect targeting relationship between LncRNA NORAD and miR-410-3p. Compared with osteosarcoma cells HOS, the expression levels of LncRNA NORAD, MRP1 mRNA and protein in osteosarcoma resistant cells HOS/DDP were significantly increased, and miR-410-3p expression levels were significantly reduced (P<0.05). Low expression of NORAD or high expression of miR-410-3p, CyclinD1, MRP1 expression levels were significantly reduced, the cell survival rate was significantly reduced, and the half inhibitory concentration of cisplatin was significantly reduced (P<0.05). LncRNA NORAD targets and regulates miR-410-3p, and low expression of miR-410-3p can reverse the effects of low NORAD expression on HOS/DDP cell proliferation and cisplatin resistance. Low expressions of NORAD, p-p65, p-IкBα protein expression levels were significantly reduced; low expression of miR-410-3p could reverse the inhibitory effect of low NORAD expression on p-p65, p-IкBα protein expression. Inhibition of LncRNA NORAD expression can inhibit the proliferation of osteosarcoma HOS/DDP cells through targeted regulation of miR-410-3p, increasing its sensitivity to cisplatin, and it may be related to the NF-κB signaling pathway." @default.
• W3034605260 created "2020-06-19" @default.
• W3034605260 creator A5009788784 @default.
• W3034605260 creator A5011733673 @default.
• W3034605260 creator A5016082098 @default.
• W3034605260 creator A5038776482 @default.
• W3034605260 creator A5060805738 @default.
• W3034605260 creator A5091378454 @default.
• W3034605260 date "2020-06-05" @default.
• W3034605260 modified "2023-09-30" @default.
• W3034605260 title "LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma" @default.
• W3034605260 cites W2404392166 @default.
• W3034605260 cites W2581999303 @default.
• W3034605260 cites W2767216588 @default.
• W3034605260 cites W2768992629 @default.
• W3034605260 cites W2883126454 @default.
• W3034605260 cites W2902775256 @default.
• W3034605260 cites W2936557674 @default.
• W3034605260 cites W2941310332 @default.
• W3034605260 cites W2945947772 @default.
• W3034605260 cites W2996676099 @default.
• W3034605260 cites W3032720311 @default.
• W3034605260 doi "https://doi.org/10.14715/cmb/2020.66.3.22" @default.
• W3034605260 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32538761" @default.
• W3034605260 hasPublicationYear "2020" @default.
• W3034605260 type Work @default.
• W3034605260 sameAs 3034605260 @default.
• W3034605260 citedByCount "12" @default.
• W3034605260 countsByYear W30346052602020 @default.
• W3034605260 countsByYear W30346052602021 @default.
• W3034605260 countsByYear W30346052602022 @default.
• W3034605260 countsByYear W30346052602023 @default.
• W3034605260 crossrefType "journal-article" @default.
• W3034605260 hasAuthorship W3034605260A5009788784 @default.
• W3034605260 hasAuthorship W3034605260A5011733673 @default.
• W3034605260 hasAuthorship W3034605260A5016082098 @default.
• W3034605260 hasAuthorship W3034605260A5038776482 @default.
• W3034605260 hasAuthorship W3034605260A5060805738 @default.
• W3034605260 hasAuthorship W3034605260A5091378454 @default.
• W3034605260 hasConcept C104317684 @default.
• W3034605260 hasConcept C127561419 @default.
• W3034605260 hasConcept C1491633281 @default.
• W3034605260 hasConcept C153911025 @default.
• W3034605260 hasConcept C199835354 @default.
• W3034605260 hasConcept C2776415932 @default.
• W3034605260 hasConcept C2776694085 @default.
• W3034605260 hasConcept C2777760704 @default.
• W3034605260 hasConcept C2778239845 @default.
• W3034605260 hasConcept C29537977 @default.
• W3034605260 hasConcept C502942594 @default.
• W3034605260 hasConcept C53227056 @default.
• W3034605260 hasConcept C54009773 @default.
• W3034605260 hasConcept C54355233 @default.
• W3034605260 hasConcept C55493867 @default.
• W3034605260 hasConcept C81885089 @default.
• W3034605260 hasConcept C86803240 @default.
• W3034605260 hasConceptScore W3034605260C104317684 @default.
• W3034605260 hasConceptScore W3034605260C127561419 @default.
• W3034605260 hasConceptScore W3034605260C1491633281 @default.
• W3034605260 hasConceptScore W3034605260C153911025 @default.
• W3034605260 hasConceptScore W3034605260C199835354 @default.
• W3034605260 hasConceptScore W3034605260C2776415932 @default.
• W3034605260 hasConceptScore W3034605260C2776694085 @default.
• W3034605260 hasConceptScore W3034605260C2777760704 @default.
• W3034605260 hasConceptScore W3034605260C2778239845 @default.
• W3034605260 hasConceptScore W3034605260C29537977 @default.
• W3034605260 hasConceptScore W3034605260C502942594 @default.
• W3034605260 hasConceptScore W3034605260C53227056 @default.
• W3034605260 hasConceptScore W3034605260C54009773 @default.
• W3034605260 hasConceptScore W3034605260C54355233 @default.
• W3034605260 hasConceptScore W3034605260C55493867 @default.
• W3034605260 hasConceptScore W3034605260C81885089 @default.
• W3034605260 hasConceptScore W3034605260C86803240 @default.
• W3034605260 hasIssue "3" @default.
• W3034605260 hasLocation W30346052601 @default.
• W3034605260 hasOpenAccess W3034605260 @default.
• W3034605260 hasPrimaryLocation W30346052601 @default.
• W3034605260 hasRelatedWork W1948889165 @default.
• W3034605260 hasRelatedWork W1965214137 @default.
• W3034605260 hasRelatedWork W2071110157 @default.
• W3034605260 hasRelatedWork W2348042013 @default.
• W3034605260 hasRelatedWork W2358576363 @default.
• W3034605260 hasRelatedWork W2365174857 @default.
• W3034605260 hasRelatedWork W2889145277 @default.
• W3034605260 hasRelatedWork W2988730021 @default.
• W3034605260 hasRelatedWork W3029549195 @default.
• W3034605260 hasRelatedWork W3129047911 @default.
• W3034605260 hasVolume "66" @default.
• W3034605260 isParatext "false" @default.
• W3034605260 isRetracted "false" @default.
• W3034605260 magId "3034605260" @default.
• W3034605260 workType "article" @default.